English  |  正體中文  |  简体中文  |  2853504  
???header.visitor??? :  45185021    ???header.onlineuser??? :  845
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pu y s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 176-200 of 627  (26 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-10-14T02:45:20Z Outcomes of stratified transurethral resection of bladder tumor: A propensity score-matched analysis Huang W.-L.; CHAO-YUAN HUANG; Huang K.-H.; Pu Y.-S.; Chang H.-C.; Chow P.-M.
臺大學術典藏 2021-10-14T02:45:18Z Outcomes and prediction models for exclusive prostate bed salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy Tseng C.-S.; Wang Y.-J.; Chen C.-H.; Wang S.-M.; Huang K.-H.; Chow P.-M.; Pu Y.-S.; CHAO-YUAN HUANG; Cheng J.C.-H.
臺大學術典藏 2021-09-04T06:24:13Z Antiandrogen hepatotoxicity in patients with chronic viral hepatitis Pu Y.-S.; Liu C.-M.; JIA-HORNG KAO; Chen J.; Lai M.-K.
臺大學術典藏 2021-09-01T02:02:46Z Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study ANN-LII CHENG; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; Pu Y.-S.; Hong R.-L.; Shen M.-C.; Wang C.-H.; Chen Y.-C.
臺大學術典藏 2021-09-01T02:02:44Z Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG; Hsieh C.-Y.; Su I.-J.; Lai M.-K.
臺大學術典藏 2021-09-01T02:02:43Z Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapy Pu Y.-S.; Hsieh T.-S.; ANN-LII CHENG; Tseng N.-F.; Su I.-J.; Hsieh C.-Y.; Lai M.-K.; Tsai T.-C.
臺大學術典藏 2021-09-01T02:02:43Z Expression of mdr-1 gene in transitional cell carcinoma and its correlation with chemotherapy response Pu Y.-S.; Tsai T.-C.; ANN-LII CHENG; Tsai C.-Y.; Tseng N.-F.; Su I.H.-J.; Hsieh C.-Y.; Lai M.-K.
臺大學術典藏 2021-09-01T02:02:35Z Megestrol acetate antagonizes cisplatin cytotoxicity Pu Y.-S.; ANN-LII CHENG; Chen J.; Guan J.-Y.; Lu S.-H.; Lai M.-K.; Hsieh C.-Y.
臺大學術典藏 2021-09-01T02:02:30Z Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma Hsu C.-H.; Chen J.; Wu C.-Y.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T02:02:30Z A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer Lin C.-C.; Hsu C.-H.; Chen J.; Tsai T.-C.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T02:02:20Z Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells Pu Y.-S.; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG; Lai M.-K.; Kuo M.-L.
臺大學術典藏 2021-09-01T02:02:11Z Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏 2021-09-01T02:02:09Z Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏 2021-09-01T02:02:06Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:33Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:32Z Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Lin C.-C.; Hsu C.-H.; Hour T.-C.; ANN-LII CHENG; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:27Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:19Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:53:49Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:29:51Z Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells Tsai Y.-C.; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:29:47Z The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; ANN-LII CHENG; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:29:34Z A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-08-20T04:14:44Z Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma Chen Y.-M.; Wu K.-D.; KUAN-YU HUNG; Pu Y.-S.; Hsieh B.-S.
臺大學術典藏 2021-08-19T10:18:40Z Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 Hsu Y.-H.; Lin W.-L.; Hou Y.-T.; Pu Y.-S.; Shun C.-T.; Chen C.-L.; Wu Y.-Y.; Chen J.-Y.; Chen T.-H.; TZUU-SHUH JOU
臺大學術典藏 2021-08-18T07:39:06Z Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma JHE-CYUAN GUO; Tsai Y.-C.; Pu Y.-S.

Showing items 176-200 of 627  (26 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page